PP63. AIDIT AND IMPACT: STRENGTHENING RESEARCH TIES IN EASTERN EUROPE
Luleci G1, Doherty R2, Lubinski J3, MANGUOGLU E1, Christie M2, Bancroft E2, Mitra A2, Morgan S2, Zieba K3, Eeles R2 1. Department of Medical Biology and Genetics, Faculty of Medicine, Akdeniz University, Antalya, Turkey; 2. The Institute of Cancer Research, London, United Kingdom; 3. International Hereditary Cancer Centre, Pomeranian Medical University, Szczecin, Poland e-mail: luleci@akdeniz.edu.tr
*Corresponding Author:
page: 76

Abstract

AIDIT (Advancing International Co-operation and Developing Infrastructure for Targeted Screening of Prostate Cancer in Men with Genetic Predisposition) is a project funded by the Sixth Framework Programme of the European Community which aims to facilitate co-operation between European countries in the field of cancer research. AIDIT will focus on linking clinical and research teams in associated candidate countries and new member states of the European Union with the IMPACT consortium, an international team investigating screening and diagnosis for men with a genetic risk of prostate cancer (carriers of BRCA1 or BRCA2 gene mutations). Cancer research is most successful when centralised and well co-ordinated, avoiding the duplication and fragmentation associated with smaller, isolated studies. AIDIT provides the opportunity for teams who might be new to this field of research to become integrated into an existing study. Communication between new and existing collaborators will allow the sharing of knowledge and formulation of strategies to overcome local barriers and challenges. AIDIT will establish and present a website to facilitate communication between project collaborators, and arrange a funded conference to bring together international research teams, clinicians and policy makers. The project will also aim to raise awareness of familial prostate cancer among health professionals and the public within Associate Candidate Countries and New Member States of the EU. Enquiries about attending the conference are welcome. This poster reflects only the authors' views. The European Community is not liable for any use that may be made of the information contained therein.




Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006